Study of a new drug for chemo nausea and vomiting
Part of Cancer clinical trials.
This trial tests a medication called LY3537021 to see if it can prevent nausea and vomiting caused by certain types of chemotherapy (AC or cisplatin) in people who have not had chemo before. It focuses on patients who are otherwise in fairly good health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have never had chemotherapy before.
- Your planned chemotherapy includes AC or cisplatin, given on one day followed by 4 days of rest.
- You are able to take care of daily activities (ECOG score 0-2).
- You do not have untreated or active brain tumors causing symptoms.
- You do not have uncontrolled diabetes, significant heart issues, or a history of thyroid tumors.
- You have not taken GIP or GLP-1 drugs (like Ozempic) in the last 4 weeks.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new form of megestrol acetate to prevent nausea and vomiting caused by chemotherapy in people with advanced stomach cancer who haven't had chemo before. It's for those starting a specific chemo combo that includes a PD-1 inhibitor and CAPOX.
This trial tests a new injection, HSK21542, to see if it can prevent nausea and vomiting caused by strong chemotherapy drugs. It may help people who have never had chemo before.
This trial studies whether palonosetron helps prevent nausea and vomiting caused by chemotherapy that has a moderate risk of vomiting. It may help you feel more comfortable during chemo and avoid treatment interruptions from severe nausea.
This Phase 4 study tests whether taking anti-nausea medicines through a vein (IV) or by mouth (oral) works better when combined to prevent nausea from breast cancer chemotherapy. It also checks safety, meaning side effects and how well people tolerate the medicines.
This trial tests if giving anti-nausea drugs based on your genetic makeup can better prevent vomiting and nausea from chemotherapy for early breast cancer. You will receive a personalized regimen tailored to your pharmacogenetic profile.
This trial tests two anti-nausea medications, Rolapitant and Palonosetron, to see how well they prevent nausea and vomiting in people with lung cancer who are receiving both chemotherapy and radiation. The study aims to help patients manage these side effects better during treatment.
Hear when a new Nausea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.